These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28728424)

  • 1. False-negative results in the immunoassay analysis of drugs of abuse: can adulterants be detected by sample check test?
    Matriciani B; Huppertz B; Keller R; Weiskirchen R
    Ann Clin Biochem; 2018 May; 55(3):348-354. PubMed ID: 28728424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug screening in urine by cloned enzyme donor immunoassay (CEDIA) and kinetic interaction of microparticles in solution (KIMS): a comparative study.
    Schwettmann L; Külpmann WR; Vidal C
    Clin Chem Lab Med; 2006; 44(4):479-87. PubMed ID: 16599844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determining the effects of adulterants on drug detection via enzyme-linked immunosorbent assay and adulterant tests strips.
    Olivieri B; Marić M; Bridge C
    Drug Test Anal; 2018 Sep; 10(9):1383-1393. PubMed ID: 29749024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of cloned enzyme donor immunoassay cut-offs for drugs of abuse in whole blood of drivers involved in road accidents.
    Pelletti G; Garagnani M; Rossi F; Roffi R; Barone R; Pelotti S
    Forensic Sci Int; 2019 Jan; 294():27-33. PubMed ID: 30447484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adulterants in Urine Drug Testing.
    Fu S
    Adv Clin Chem; 2016; 76():123-63. PubMed ID: 27645818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of five abused drugs in nitrite-adulterated urine by immunoassays and gas chromatography-mass spectrometry.
    Tsai SC; ElSohly MA; Dubrovsky T; Twarowska B; Towt J; Salamone SJ
    J Anal Toxicol; 1998 Oct; 22(6):474-80. PubMed ID: 9788522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of LUCIO®-direct ELISA with CEDIA immunoassay for 'zero tolerance' drug screening in urine as required by the German re-licensing guidelines.
    Agius R; Nadulski T; Kahl HG; Dufaux B
    Drug Test Anal; 2013 Jun; 5(6):390-9. PubMed ID: 23349145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of an Automated Reader and Color Interpretation-Based Immunoassays for Multiplexed Drug-of-Abuse Testing in Urine.
    Kim SY; Kim H; Park Y; Lim J; Kim J; Koo SH; Kwon GC
    J Anal Toxicol; 2017 Jun; 41(5):412-420. PubMed ID: 28201761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of CEDIA and DRI Drugs of Abuse Immunoassays for Urine Screening on a Thermo Indiko Plus Analyzer.
    Köhler KM; Hammer R; Riedy K; Auwärter V; Neukamm MA
    J Clin Lab Anal; 2017 Jan; 31(1):. PubMed ID: 27346579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of cloned enzyme donor immunoassay cut-offs for drugs of abuse in post-mortem whole blood.
    Pelletti G; Rossi F; Garagnani M; Barone R; Roffi R; Fais P; Pelotti S
    Forensic Sci Int; 2020 Jul; 312():110291. PubMed ID: 32353744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sample preparation method for the combined extraction of ethyl glucuronide and drugs of abuse in hair.
    Meier U; Briellmann T; Scheurer E; Dussy F
    Drug Test Anal; 2018 Apr; 10(4):701-710. PubMed ID: 28992662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Stealth adulterant on immunoassay testing for drugs of abuse.
    Cody JT; Valtier S
    J Anal Toxicol; 2001 Sep; 25(6):466-70. PubMed ID: 11550822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of adulterants on urine screen for drugs of abuse: detection by an on-site dipstick device.
    Wong R
    Am Clin Lab; 2002; 21(1):37-9. PubMed ID: 11975450
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of KIMS immunoassays on a cobas c 501 analyzer for drugs of abuse and ethyl glucuronide testing in urine for forensic abstinence control.
    Neukamm MA; Bahrami A; Auwärter V; Mehne FMP; Höss E
    Drug Test Anal; 2017 Aug; 9(8):1217-1223. PubMed ID: 28024169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of adulterating agents on FPIA analysis of urine for drugs of abuse.
    Schwarzhoff R; Cody JT
    J Anal Toxicol; 1993; 17(1):14-7. PubMed ID: 8429620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detectability of new psychoactive substances, 'legal highs', in CEDIA, EMIT, and KIMS immunochemical screening assays for drugs of abuse.
    Beck O; Rausberg L; Al-Saffar Y; Villen T; Karlsson L; Hansson T; Helander A
    Drug Test Anal; 2014 May; 6(5):492-9. PubMed ID: 24665024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of several immunoassays used in drugs of abuse screening: Assessment against gold standard methods and calculation of measurement uncertainty.
    Mina A
    J Pharmacol Toxicol Methods; 2020; 101():106649. PubMed ID: 31730939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adulteration of urine by "Urine Luck".
    Wu AH; Bristol B; Sexton K; Cassella-McLane G; Holtman V; Hill DW
    Clin Chem; 1999 Jul; 45(7):1051-7. PubMed ID: 10388482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance characteristics of DRI, CEDIA, and REMEDi systems for preliminary tests of amphetamines and opiates in human urine.
    Huang MK; Dai YS; Lee CH; Liu C; Tsay WI; Li JH
    J Anal Toxicol; 2006; 30(1):61-4. PubMed ID: 16620534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of adulterants and selected ingested compounds on drugs-of-abuse testing in urine.
    Dasgupta A
    Am J Clin Pathol; 2007 Sep; 128(3):491-503. PubMed ID: 17709324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.